Quick Answer
ImmunityBio, Inc. reported Total Assets of $501.90 million for fiscal year 2025.
ImmunityBio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $501.90M | +31.1% |
| 2024 | $382.93M | -24.1% |
| 2023 | $504.45M | +39.2% |
| 2022 | $362.36M | -22.7% |
| 2021 | $468.91M | +111.8% |
| 2020 | $221.38M | +54.7% |
| 2019 | $143.12M | -21.3% |
| 2018 | $181.95M | -27.3% |
| 2017 | $250.44M | -21.1% |
| 2016 | $317.50M | -13.5% |
| 2015 | $366.85M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $518.99M | +42.4% | +29.1% |
| June 30, 2025 | $402.08M | -9.5% | +32.4% |
| March 31, 2025 | $303.76M | -24.2% | -20.7% |
| December 31, 2024 | $382.93M | -24.1% | +5.0% |
| September 30, 2024 | $364.57M | -15.7% | -17.9% |
| June 30, 2024 | $444.32M | +52.6% | +10.9% |
| March 31, 2024 | $400.68M | +16.7% | -20.6% |
| December 31, 2023 | $504.45M | +39.2% | +16.7% |
- ImmunityBio, Inc. showed an increase of +31.1% in Total Assets compared to the prior fiscal year.
- Over the 2015–2025 period, ImmunityBio, Inc.’s total assets has grown by 36.8% (from $366.85 million to $501.90 million).
- The most recent figure is from ImmunityBio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: